FDA recall D-0155-2017

Burel Pharmaceuticals Inc · Class II · drug

Product

Hyolev MB URINARY ANTISEPTIC Tablets, Each tablet for oral administration contains: Hyoscyamine Sulfate 0.12 mg, Methenamine 81 mg, Methylene Blue 10.8 mg, Phenyl Salicylate 32.4 mg, Sodium Phosphate Monobasic 40.8 mg, 90 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS --- NDC 35573-301-90

Reason for recall

CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2016-10-24
Report date
2016-12-07
Termination date
2017-08-14
Voluntary/Mandated
Voluntary: Firm initiated
Location
Richland, MS, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0155-2017